Cooperative Agreement U1ADP002872

This Project Grant award of $1,226,040.00 from the National Cancer Institute (NCI), under the CFDA 93.393 Cancer Cause and Prevention Research program, aims to develop and evaluate a culturally-tailored suite of smoking cessation resources for American Indian (AI) persons. The project will: 1) Co-create a culturally-aligned website, Smokefree.gov for Natives, to serve as the landing page for AI-tailored online cessation content and resources; 2) Conduct a randomized controlled trial to test...

The Navajo Nation Tribal Government received a $5,569,436 Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The grant aims to address the emerging public health concern of opioid misuse and protect the health and safety of the Navajo Nation, which has an estimated user population of 238,951 through the Navajo Area Indian Health...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $1,249,386 to Arizona State University (ASU) to leverage community-engaged research to co-create youth vaping prevention strategies with urban Indigenous communities in the Southwest United States. The key objectives are to: 1) identify multilevel risk and protective factors for nicotine and cannabis vaping among urban Indigenous youth, 2)...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,590,383 Cooperative Agreement to the Southern Plains Tribal Health Board Foundation under the Assistance Programs for Chronic Disease Prevention and Control (CFDA 93.945) program. The purpose of this five-year grant, with a start date of September 30, 2024, is to support research, intervention, and awareness initiatives related to chronic disease prevention and management in tribal communities across Oklahoma, Kansas, and...

This $982,800 Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to leverage genome-wide and epigenome-wide association studies to better understand the relationship between nicotine metabolism, smoking cessation, and tobacco-related health outcomes in American Indian (AI) communities. The research project will be conducted by the University of Colorado-Denver and will involve a three-phased approach: 1)...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nation's Health program (CFDA 93.421) provides $684,114 to the Navajo Nation Tribal Government over a 5-year period from FY2024 to FY2029. The funding will support a cultural approach to good health and wellness initiatives for the Navajo Community Health Representative Program (CHR) in the...

This Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance (CFDA 93.243) program provides $500,000 to the Northern Arapaho Tribe in Wyoming to develop culturally-informed and evidence-based community prevention efforts addressing opioid and stimulant misuse. The key products and services to be delivered through this 5-year project include: implementing...

The Tohono O'Odham Nation was awarded a $657,731 Project Grant from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243). The grant will fund the Tohono O'Odham Nation Opioid Response Project to address the opioid and illicit drug crisis among the Tohono O'Odham Nation's 36,000 members, with a focus on both on- and off-reservation tribal members as well as...

The federal Project Grant award R01CA289551 for $661,139, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, supports a 6-month randomized clinical trial to evaluate the effectiveness of oral nicotine pouches (ONPs) versus nicotine replacement therapy (NRT) in reducing smoking among adult smokers in rural Appalachian counties. The study, conducted by The Ohio State University, aims to determine whether ONPs are suitable...

This Project Grant award from the National Institutes of Health's Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $1,197,896 to the University of Oklahoma Health Sciences Center to conduct a longitudinal study examining the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors and abuse liability among young adults aged 18-25. The research aims to use a novel measurement approach combining traditional...